Retroperitoneoscopic nephrectomy for huge autosomal-dominant polycystic kidney disease using morcellator

使用组织粉碎器行腹膜后镜肾切除术治疗巨大型常染色体显性多囊肾病

阅读:1

Abstract

INTRODUCTION AND OBJECTIVES: Nephrectomy is occasionally required due to severe extra-renal symptom(s) such as dyspepsia in patients with autosomal dominant polycystic kidney disease (ADPKD), wherein a large incision is required for specimen extraction. Considering problems such as hernia, wound dehiscence, incidental bowel injury, and poor wound healing in such cases, we would like to present retroperitoneoscopic nephrectomy and morcellation of the kidney as an ideal minimally invasive technique. MATERIALS AND METHODS: A 53-year-old man who was undergoing hemodialysis for 6 years due to ADPKD visited the outpatient clinic with a complaint of severe dyspepsia. Kidney length (long axis) was greater than 28 cm. Nephrectomy was the last option to restore his digestive system which was mechanically compressed by an extremely enlarged polycystic kidney. Retroperitoneoscopic nephrectomy was performed using 3 ports. When it was difficult to continue the dissection due to limited space, large cysts were punctured and aspirated to create additional working space. The specimen was extracted by a morcellator (KARL STORZ GmbH & Co. KG, Tuttlingen, Germany) introduced through a 12mm trocar. RESULTS: Operating time was 230 minutes, wherein the time for morcellation was 52 minutes. No additional incision was required for specimen extraction. He underwent hemodialysis on post-operative days #1 and #3. He was discharged on post-operative day #4 (total hospital stay was 6 days.). Dyspepsia dramatically improved without post-operative complications. CONCLUSIONS: Retroperitoneoscopic nephrectomy is feasible for treatment of ADPKD. By using a morcellator, an additional incision is not required and wound complication would not occur.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。